Valuation: Alembic Pharmaceuticals Limited

Market Cap 161B 1.69B 1.48B 1.37B 1.26B 2.38B 2.43B 16.33B 6.4B 79.26B 6.33B 6.19B 274B P/E 2027 *
21.9x
P/E 2028 * 17.2x
Enterprise Value 171B 1.78B 1.57B 1.45B 1.33B 2.52B 2.57B 17.28B 6.78B 83.89B 6.7B 6.56B 290B EV / Sales 2027 *
2.08x
EV / Sales 2028 * 1.8x
Free-Float
29.3%
Yield 2027 *
1.55%
Yield 2028 * 1.83%
1 day-1.19%
1 week-1.74%
Current month-0.19%
1 month+10.47%
3 months+14.45%
6 months+2.50%
Current year-2.95%
1 week 801.25
Extreme 801.25
845
1 month 735.55
Extreme 735.55
846
Current year 635.8
Extreme 635.8
847.95
1 year 635.8
Extreme 635.8
1,044.8
3 years 635.8
Extreme 635.8
1,303.9
5 years 462.3
Extreme 462.3
1,303.9
10 years 414.4
Extreme 414.4
1,303.9
Manager TitleAgeSince
Director of Finance/CFO - 2025-07-06
Chief Operating Officer - 2025-07-20
Chief Tech/Sci/R&D Officer - 2023-06-30
Director TitleAgeSince
Chairman 78 2012-06-07
Director/Board Member 50 2006-12-31
Director/Board Member 66 2003-01-17
Date Insider Type Main position Quantity % Market Cap.
25-03-27
Nirayu Pvt Ltd.
BuyCompany 12,665 0.0064%
25-03-23
Nirayu Pvt Ltd.
BuyCompany 7,600 0.0039%
25-03-20Buy 2,000 0.0010%
Change 5-day change 1-year change 3-year change Capi.($)
-1.19%-1.74%-15.92%+25.80% 1.71B
-2.47%-7.04%+43.69%+155.54% 1,054B
-1.97%-5.51%+61.02%+57.95% 621B
-1.24%-4.07%+27.55%+79.61% 438B
-1.33%-3.98%+26.50%+20.21% 325B
-1.97%-3.68%+26.66%+43.76% 281B
-1.69%-13.73%+16.23%+20.03% 262B
-1.45%-2.37%-27.87%-39.87% 219B
-0.97%-3.03%+20.17%+56.94% 195B
-0.89%-4.58%+16.08%+68.56% 163B
Average -1.50%-1.59%+19.41%+48.85% 355.79B
Weighted average by Cap. -1.78%-1.68%+32.81%+76.57%

Financials

2027 *2028 *
Net sales 82.16B 858M 753M 697M 642M 1.21B 1.24B 8.31B 3.26B 40.34B 3.22B 3.15B 139B 90.29B 943M 827M 766M 705M 1.33B 1.36B 9.13B 3.58B 44.34B 3.54B 3.47B 153B
Net income 7.51B 78.49M 68.85M 63.77M 58.67M 111M 113M 760M 298M 3.69B 295M 288M 12.74B 9.52B 99.44M 87.22M 80.78M 74.33M 141M 143M 963M 378M 4.67B 373M 365M 16.14B
Net Debt 9.43B 98.53M 86.42M 80.04M 73.65M 139M 142M 954M 374M 4.63B 370M 362M 15.99B 1.32B 13.75M 12.06M 11.17M 10.28M 19.44M 19.82M 133M 52.21M 646M 51.63M 50.5M 2.23B
Logo Alembic Pharmaceuticals Limited
Alembic Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is engaged in manufacturing and marketing Indian Formulations, International Generics, and Active Pharmaceutical Ingredients (APIs) across the globe. It delivers a diverse and expanding range of generics across chronic segments. Its therapies include Dermatology, Anti-Infective, Cold & Cough, Gastrology, Cardiology, Anti-Diabetic, Ophthalmology, Nephro/Uro, Animal Health, Orthopedic and Gynecology. Its products under International Generics are manufactured across its facilities in Panelav, Karkhadi and Jarod in Gujarat. It also has research and development facilities in Vadodara (Gujarat), Hyderabad (Telangana), and New Jersey (United States). Its APIs are manufactured at its three plants in Panelav and Karkhadi in Gujarat. The manufacturing facility in Sikkim is for manufacturing its Indian Formulations.
Employees
17,244
Date Price Change Volume
26-07-14 821.15 -1.19% 122,575
26-07-13 ₹831.05 -0.76% 101,420
26-07-10 ₹837.40 +2.51% 109,731
26-07-09 ₹816.90 +0.69% 62,063
26-07-08 ₹811.30 -2.18% 150,088
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
831.05INR
Average target price
918.20INR
Spread / Average Target
+10.49%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. APLLTD Stock